XML 14 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Net Cash flows used from operating activities:    
Net loss $ (26,945,976) $ (8,418,831)
Adjustments to reconcile net loss to net cash used in provided by operating activities:    
Depreciation and amortization expenses 181,134 205,240
Stock based compensation 6,383,772
Change in fair value of digital currencies (8,665) (7,476)
Loss on sale of fixed assets 11,002
Issuance of common stock for services 189,855
Issuance of derivative liability warrants for services 100,000
Loss on issuance of units 250,000 1,050,911
Fair value adjustments for warrant liabilities 8,183,196 (610,039)
Fair value adjustments for convertible notes 3,245,896
Fair value adjustments for derivative liability shortfall of shares 7,401,321
Inducement expenses 58,380
Impairment loss related to investment 2,250,000 254,433
Impairment loss on fixed assets 240,853
Loss on extinguishment of debt 2,859,338
Liquidated damages 1,621,750
Changes in operating assets and liabilities:    
Digital currencies 25,501 (37,790)
Prepaid expenses and other current assets (394) 24,027
Accounts payable 260,499 292,906
Net cash used in operating activities (674,545) (514,612)
Net cash used in investing activities:    
Purchase of property and equipment (19,238) (531,434)
Sale of property and equipment, net 57,335 4,141
Refund of lease deposit 310,889 (51,885)
Investments at cost (1,600,000)
Net cash provided by (used in) investing activities 348,986 (2,179,178)
Net cash provided by financing activities:    
Common stock repurchase (2,500)
Net proceeds from exercise of warrant 91,766
Net proceeds from issuance of Private Placement Units 2,695,500
Net proceeds from issuance of Private Placement Units from related party 50,000
Proceeds from short term loan 45,000
Proceeds from issuance of convertible notes, net 100,000
Payment on short term loan to related party (7,990)
Change in overdraft 9,258
Net cash provided by financing activities 201,024 2,780,010
Net decrease in cash (124,535) 86,220
Cash, beginning of period 124,535 5,403
Cash, end of period 91,623
Supplemental disclosure of non-cash financing and investing activities:    
Conversion of Series C Convertible Preferred to common stock 2,200
Issuance of common stock for fixed assets purchases 48,626
Conversion of accounts payable to common stock 246,924
Issuance of common stock for investment 154,433
Cashless warrant exercise 212,230
Conversion of convertible notes to common stock 5,409,571
Debt settlement from sale of fixed assets 22,200
Reclassification between convertible notes and derivative liabilities $ 92,601